Adlyxin Archives • NCK Pharma

Key finding from USFDA’s new drug approval in the year 2016

Posted on01 Jan 2017

Tags2016 new drug approval, Adlyxin, Anthim, Axumin, Briviact, Cinqair, Defitelio, Epclusa, Eucrisa, Exondys 51, Lartruvo, MAB, NETSPOT, Nuplazid, OCALIVA, Rubraca, Spinraza, Taltz, Tecentriq, Venclexta, Xiidra, Zepatier, Zinbryta, Zinplava

Comments0

Total 22 New Molecule approved in the year 2016. New Molecule includes drugs and biopharmaceuticals. 7 new monoclonal antibody are approved in...

Insight of USFDA approval of Adlyxin to treat type 2 diabetes

Posted on09 Aug 2016

TagsAdlyxin, Sanofi

Comments0

The U.S. Food and Drug Administration approved Sanofi-Aventis’s Adlyxin (lixisenatide), a once-daily injection to improve glycemic control (blood sugar levels), along with...

Sanofi Receives FDA Approval of Adlyxin for Treatment of Adults with Type 2 Diabetes

Posted on29 Jul 2016

TagsAdlyxin, Sanofi, Type 2 Diabetes

Comments0

Sanofi announced today that the U.S. Food and Drug Administration (FDA) approved AdlyxinTM (lixisenatide), a once-daily mealtime GLP-1 receptor agonist injection indicated...